MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David W. Tucker who wrote (520)	8/10/2000 12:14:48 PM
From: Exacctnt	Read Replies (2) of 2240

MEDX Q2 loss misses views Medarex (MEDX: news, msgs) is sinking 15 1/4, or 16.6 percent, to 76 3/4. The Princeton, N.J., biopharmaceutical firm reported a second-quarter loss of $5.6 million, or 16 cents a share, wider than last year's loss of $4.4 million, or 14 cents a share. These results, which included $5 million license payment to Eos Biotechnology, missed the average loss estimate of analysts polled by First Call by 4 cents. Sales fell in the latest three months to $58,000 from $443,000 in the same period a year earlier. www2.marketwatch.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next